Skip to content
2000
Volume 13, Issue 5
  • ISSN: 2211-7385
  • E-ISSN: 2211-7393

Abstract

Polyphenols are a group of naturally occurring compounds that have intriguing biological activities. Among these compounds is rutin, a polyphenolic flavanol found in many plants, including passion flowers, buckwheat seed, fruits and fruit rinds, and citrus fruits (such as orange, grapefruit, lemon, and lime). Various studies have demonstrated rutin to possess antibacterial, antifungal, antiallergic, anti-inflammatory, anti-diabetic, anti-adipogenic, anti-carcinogenic, anti-apoptotic, anti-osteoporotic, radioprotective, gastroprotective, neuroprotective, and nephroprotective activities. Despite its benefits, rutin's therapeutic applicability is severely limited due to its low water solubility, sensitivity to oxidation, and dissolving rate. However, these problems can be overcome by employing an efficient delivery approach. An extensive number of nanocarriers can be developed for medicinal use if pre-clinical as well as human-clinical studies are completed. The current review presents an overview of effective rutin nano-formulations for targeted therapy in various health disorders. This review article discusses the clinical evidence, current status, as well as future opportunities of rutin nanocarriers for increasing rutin's bioactivity for possible medicinal uses.

Loading

Article metrics loading...

/content/journals/pnt/10.2174/0122117385308249240723111115
2025-10-01
2025-11-14
Loading full text...

Full text loading...

References

  1. HoaiT.T. YenP.T. DaoT.T.B. LongL.H. AnhD.X. MinhL.H. AnhB.Q. ThuongN.T. Evaluation of the cytotoxic effect of rutin prenanoemulsion in lung and colon cancer cell lines.J. Nanomater.2020202011110.1155/2020/8867669
    [Google Scholar]
  2. ManachC. MorandC. DemignéC. TexierO. RégératF. RémésyC. Bioavailability of rutin and quercetin in rats.FEBS Lett.19974091121610.1016/S0014‑5793(97)00467‑59199494
    [Google Scholar]
  3. GeraS. PooladandaV. GoduguC. Swamy ChallaV. WankarJ. DodoalaS. SampathiS. Rutin nanosuspension for potential management of osteoporosis: Effect of particle size reduction on oral bioavailability, in vitro and in vivo activity.Pharm. Dev. Technol.202025897198810.1080/10837450.2020.176537832403972
    [Google Scholar]
  4. MauludinR. MüllerR.H. Preparation and storage stability of rutin nanosuspensions.J. Pharm. Investig.201343539540410.1007/s40005‑013‑0084‑1
    [Google Scholar]
  5. Lopez-PoloJ. Silva-WeissA. GiménezB. Cantero-LópezP. VegaR. OsorioF.A. Effect of lyophilization on the physicochemical and rheological properties of food grade liposomes that encapsulate rutin.Food Res. Int.202013013010896710.1016/j.foodres.2019.10896732156401
    [Google Scholar]
  6. ShafiW. MansoorS. JanS. SinghD. KaziM. RaishM. AlwadeiM. MirJ. AhmadP. Variability in catechin and rutin contents and their antioxidant potential in diverse apple genotypes.Molecules201924594310.3390/molecules2405094330866542
    [Google Scholar]
  7. ChahyadiA. Elfahmi The influence of extraction methods on rutin yield of cassava leaves (Manihot esculenta Crantz).Saudi Pharm. J.202028111466147310.1016/j.jsps.2020.09.01233250654
    [Google Scholar]
  8. JavedH. KhanM.M. AhmadA. VaibhavK. AhmadM.E. KhanA. AshafaqM. IslamF. SiddiquiM.S. SafhiM.M. IslamF. Rutin prevents cognitive impairments by ameliorating oxidative stress and neuroinflammation in rat model of sporadic dementia of Alzheimer type.Neuroscience201221034035210.1016/j.neuroscience.2012.02.04622441036
    [Google Scholar]
  9. RichettiS.K. BlankM. CapiottiK.M. PiatoA.L. BogoM.R. ViannaM.R. BonanC.D. Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish.Behav. Brain Res.20112171101510.1016/j.bbr.2010.09.02720888863
    [Google Scholar]
  10. La CasaC. VillegasI. Alarcón de la LastraC. MotilvaV. Martín CaleroM.J. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions.J. Ethnopharmacol.2000711-2455310.1016/S0378‑8741(99)00174‑910904145
    [Google Scholar]
  11. TrumbeckaiteS. BernatonieneJ. MajieneD. JakštasV. SavickasA. ToleikisA. The effect of flavonoids on rat heart mitochondrial function.Biomed. Pharmacother.200660524524810.1016/j.biopha.2006.04.00316777369
    [Google Scholar]
  12. RashidinejadA. JamesonG. SinghH. The effect of ph and sodium caseinate on the aqueous solubility, stability, and crystallinity of rutin towards concentrated colloidally stable particles for the incorporation into functional foods.Molecules202227253410.3390/molecules2702053435056844
    [Google Scholar]
  13. YıldırımM. AcetÖ. YetkinD. AcetB.Ö. KarakocV. OdabasıM. Anti-cancer activity of naringenin loaded smart polymeric nanoparticles in breast cancer.J. Drug Deliv. Sci. Technol.20227410355210.1016/j.jddst.2022.103552
    [Google Scholar]
  14. Ruzycka-AyoushM. KowalikP. KowalczykA. BujakP. NowickaA.M. WojewodzkaM. KruszewskiM. GrudzinskiI.P. Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells.Cancer Nanotechnol.2021121810.1186/s12645‑021‑00077‑9
    [Google Scholar]
  15. Al-MahdaweM.M. Al-MallahM.K. AhmadT.A. Isolation and identification of rutin from tissues cultures of Ruta graveolens L.J. Pharm. Sci. Res.201810615171520
    [Google Scholar]
  16. HabtemariamS. VargheseG. Extractability of rutin in herbal tea preparations of moringa stenopetala leaves.Beverages20151316918210.3390/beverages1030169
    [Google Scholar]
  17. ChaturvediS. MishraR. Insight into delivery approaches for biopharmaceutics classification system class II and IV drugs.Drug Deliv. Lett.202010425527710.2174/2210303110999200712185109
    [Google Scholar]
  18. LiuY. ZhaoX. ZhangQ. WangL. LiY. LiY. Characterization and evaluation of the solubility and oral bioavailability of rutin–ethanolate solvate.AAPS PharmSciTech202021724110.1208/s12249‑020‑01779‑w32839899
    [Google Scholar]
  19. Domínguez MoréG.P. FeltrinC. BrambilaP.F. CardonaM.I. EcheverryS.M. SimõesC.M.O. AragónD.M. Matrix effects of the hydroethanolic extract and the butanol fraction of calyces from Physalis peruviana L. on the biopharmaceutics classification of rutin.J. Pharm. Pharmacol.202072573874710.1111/jphp.1324832162346
    [Google Scholar]
  20. AmarettiA. RaimondiS. LeonardiA. QuartieriA. RossiM. Hydrolysis of the rutinose-conjugates flavonoids rutin and hesperidin by the gut microbiota and bifidobacteria.Nutrients2015742788280010.3390/nu704278825875120
    [Google Scholar]
  21. MuellerM. ZartlB. SchleritzkoA. StenzlM. ViernsteinH. UngerF.M. Rhamnosidase activity of selected probiotics and their ability to hydrolyse flavonoid rhamnoglucosides.Bioprocess Biosyst. Eng.201841222122810.1007/s00449‑017‑1860‑529124335
    [Google Scholar]
  22. RivaA. KolimárD. SpittlerA. WisgrillL. HerboldC.W. AbrankóL. BerryD. Conversion of rutin, a prevalent dietary flavonol, by the human gut microbiota.Front. Microbiol.202011December58542810.3389/fmicb.2020.58542833408702
    [Google Scholar]
  23. CarbonaroM. GrantG. Absorption of quercetin and rutin in rat small intestine.Ann. Nutr. Metab.200549317818210.1159/00008688216006787
    [Google Scholar]
  24. HaiY. ZhangY. LiangY. MaX. QiX. XiaoJ. XueW. LuoY. YueT. Advance on the absorption, metabolism, and efficacy exertion of quercetin and its important derivatives.Food Front.20201442043410.1002/fft2.50
    [Google Scholar]
  25. Ou-yangZ. CaoX. WeiY. ZhangW.W.Q. ZhaoM. DuanJ. Pharmacokinetic study of rutin and quercetin in rats after oral administration of total flavones of mulberry leaf extract.Rev. Bras. Farmacogn.201323577678210.1590/S0102‑695X2013000500009
    [Google Scholar]
  26. ZhangX. SongJ. ShiX. MiaoS. LiY. WenA. Absorption and metabolism of rutin in Caco-2 cells.Sci. World J.201320135382350
    [Google Scholar]
  27. MukherjeeP.K. BahadurS. HarwanshR.K. BiswasS. BanerjeeS. Paradigm shift in natural product research: Traditional medicine inspired approaches.Phytochem. Rev.201716580382610.1007/s11101‑016‑9489‑6
    [Google Scholar]
  28. NegahdariR. BohlouliS. SharifiS. Maleki DizajS. Rahbar SaadatY. KhezriK. JafariS. AhmadianE. Gorbani JahandiziN. RaeesiS. Therapeutic benefits of rutin and its nanoformulations.Phytother. Res.20213541719173810.1002/ptr.690433058407
    [Google Scholar]
  29. Tobar-DelgadoE. Mejía-EspañaD. Osorio-MoraO. Serna-CockL. Rutin: Family farming products’ extraction sources, industrial applications and current trends in biological activity protection.Molecules20232815586410.3390/molecules2815586437570834
    [Google Scholar]
  30. EnogieruA.B. HaylettW. HissD.C. BardienS. EkpoO.E. Rutin as a potent antioxidant: Implications for neurodegenerative disorders.Oxid. Med. Cell. Longev.2018201811710.1155/2018/624101730050657
    [Google Scholar]
  31. SatariA. GhasemiS. HabtemariamS. AsgharianS. LorigooiniZ. Rutin: A flavonoid as an effective sensitizer for anticancer therapy; insights into multifaceted mechanisms and applicability for combination therapy.Evid. Based Complement. Alternat. Med.2021202111010.1155/2021/991317934484407
    [Google Scholar]
  32. MuvhulawaN. DludlaP.V. ZiqubuK. MthembuS.X.H. MthiyaneF. NkambuleB.B. Mazibuko-MbejeS.E. Rutin ameliorates inflammation and improves metabolic function: A comprehensive analysis of scientific literature.Pharmacol. Res.202217810616310.1016/j.phrs.2022.10616335257898
    [Google Scholar]
  33. GhorbaniA. Mechanisms of antidiabetic effects of flavonoid rutin.Biomed. Pharmacother.20179630531210.1016/j.biopha.2017.10.00129017142
    [Google Scholar]
  34. BansalK. SinghV. MishraS. BajpaiM. Articulating the pharmacological and nanotechnological aspects of genistein: Current and future prospectives.Curr. Pharm. Biotechnol.202425780782410.2174/0113892010265344230919170611
    [Google Scholar]
  35. YildirimM. AcetÖ. Immunomodulatory activities of pH/temperature sensitive smart naringenin-loaded nanopolymers on the mammalian macrophages.Applied Surface Science Advances20231810052710.1016/j.apsadv.2023.100527
    [Google Scholar]
  36. HarwanshR.K. YadavM. DeshmukhR. RahmanA. Recent insights into nanoparticulate carrier systems of curcumin and its clinical perspective in the management of various health issues.Curr. Pharm. Des.202329181421144010.2174/138161282966623061311544737312443
    [Google Scholar]
  37. BanikB.L. FattahiP. BrownJ.L. Polymeric nanoparticles: The future of nanomedicine.Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.20168227129910.1002/wnan.136426314803
    [Google Scholar]
  38. DahiyaP. ZafarA. AhmadF.J. KhalidM. AliA. Development of Forskolin and rutin-loaded polymeric nanoparticles for enhancement of topical ocular delivery: Optimization, in-vitro, ex-vivo, and toxicity evaluation.J. Drug Deliv. Sci. Technol.20238210429210.1016/j.jddst.2023.104292
    [Google Scholar]
  39. KızılbeyK. Optimization of rutin-loaded plga nanoparticles synthesized by single-emulsion solvent evaporation method.ACS Omega20194155556210.1021/acsomega.8b02767
    [Google Scholar]
  40. MalamY. LoizidouM. SeifalianA.M. Liposomes and nanoparticles: Nanosized vehicles for drug delivery in cancer.Trends Pharmacol. Sci.2009301159259910.1016/j.tips.2009.08.00419837467
    [Google Scholar]
  41. NsairatH. KhaterD. SayedU. OdehF. Al BawabA. AlshaerW. Liposomes: Structure, composition, types, and clinical applications.Heliyon202285e0939410.1016/j.heliyon.2022.e0939435600452
    [Google Scholar]
  42. GaoW. HuC.M.J. FangR.H. ZhangL. Liposome-like nanostructures for drug delivery.J. Mater. Chem. B Mater. Biol. Med.2013148656910.1039/c3tb21238f24392221
    [Google Scholar]
  43. GuoY. ShenL. LuY. LiH. MinK. LiL. YuC. ZhengX. Preparation of rutin-liposome drug delivery systems and evaluation on their in vitro antioxidant activity.Chin. Herb. Med.20168437137510.1016/S1674‑6384(16)60065‑5
    [Google Scholar]
  44. ParkS.N. LeeM.H. KimS.J. YuE.R. Preparation of quercetin and rutin-loaded ceramide liposomes and drug-releasing effect in liposome-in-hydrogel complex system.Biochem. Biophys. Res. Commun.2013435336136610.1016/j.bbrc.2013.04.09323669037
    [Google Scholar]
  45. GoniotakiM. HatziantoniouS. DimasK. WagnerM. DemetzosC. Encapsulation of naturally occurring flavonoids into liposomes: Physicochemical properties and biological activity against human cancer cell lines.J. Pharm. Pharmacol.201056101217122410.1211/002235704438215482635
    [Google Scholar]
  46. KerdudoA. DingasA. FernandezX. FaureC. Encapsulation of rutin and naringenin in multilamellar vesicles for optimum antioxidant activity.Food Chem.2014159121910.1016/j.foodchem.2014.03.00524767021
    [Google Scholar]
  47. PriyaV. SinghS.K. RevandR. KumarS. MehataA.K. SushmithaP. MahtoS.K. MuthuM.S. GPIIb/IIIa receptor targeted rutin loaded liposomes for site-specific antithrombotic effect.Mol. Pharm.202320166367910.1021/acs.molpharmaceut.2c0084836413707
    [Google Scholar]
  48. Paiva-SantosA.C. SilvaA.L. GuerraC. PeixotoD. Pereira-SilvaM. ZeinaliM. Mascarenhas-MeloF. CastroR. VeigaF. Ethosomes as nanocarriers for the development of skin delivery formulations.Pharm. Res.202138694797010.1007/s11095‑021‑03053‑534036520
    [Google Scholar]
  49. CândidoT.M. De OliveiraC.A. AriedeM.B. VelascoM.V.R. RosadoC. BabyA.R. Safety and antioxidant efficacy profiles of rutin-loaded ethosomes for topical application.AAPS PharmSciTech20181941773178010.1208/s12249‑018‑0994‑329600391
    [Google Scholar]
  50. ParkS.N. LeeH.J. GuH.A. Enhanced skin delivery and characterization of rutin-loaded ethosomes.Korean J. Chem. Eng.201431348548910.1007/s11814‑013‑0232‑3
    [Google Scholar]
  51. HooresfandZ. GhanbarzadehS. HamishehkarH. Preparation and characterization of rutin-loaded nanophytosomes.Pharm. Sci.201521314515110.15171/PS.2015.29
    [Google Scholar]
  52. MahmoodT.H. Al-SamydaiA. SulaibiM.A. AlqaralehM. AbedA.I. ShalanN. AlsanabrahA. AlsotariS.T. NsairatH. AlshaerW. Development of pegylated nano-phytosome formulation with oleuropein and rutin to compare anti-colonic cancer activity with olea europaea leaves extract.Chem. Biodivers.2023208e20230053410.1002/cbdv.20230053437498138
    [Google Scholar]
  53. BabazadehA. GhanbarzadehB. HamishehkarH. Phosphatidylcholine-rutin complex as a potential nanocarrier for food applications.J. Funct. Foods20173313414110.1016/j.jff.2017.03.038
    [Google Scholar]
  54. AmjadiS. ShahnazF. ShokouhiB. AzarmiY. Siahi-ShadbadM. GhanbarzadehS. KouhsoltaniM. EbrahimiA. HamishehkarH. Nanophytosomes for enhancement of rutin efficacy in oral administration for diabetes treatment in streptozotocin-induced diabetic rats.Int. J. Pharm.202161012120810.1016/j.ijpharm.2021.12120834673162
    [Google Scholar]
  55. WadherK. TrivediS. UmekarM. Formulation and Cytotoxic characterization of rutin loaded flexible transferosomes for topical delivery: Ex-vivo and in-vitro evaluation.SSRN202210.2139/ssrn.4145403
    [Google Scholar]
  56. WadherK. TrivediS. RarokarN. UmekarM. Development and assessment of rutin loaded transfersomes to improve ex vivo membrane permeability and in vitro efficacy.Hybrid Advances2024510014410.1016/j.hybadv.2024.100144
    [Google Scholar]
  57. AcetÖ. Design of enhanced smart delivery systems for therapeutic enzymes: Kinetic and release performance of dual effected enzyme-loaded nanopolymers.Catal. Lett.2023153103174318410.1007/s10562‑023‑04418‑8
    [Google Scholar]
  58. AfifiS.A. HassanM.A. AbdelhameedA.S. ElkhodairyK.A. Nanosuspension: An emerging trend for bioavailability enhancement of etodolac.Int. J. Polym. Sci.2015201511610.1155/2015/938594
    [Google Scholar]
  59. Saddam HussainM. Baquee AhmedA. DebnathJ. Nanosuspension: A promising drug delivery system for poorly water soluble drug and enhanced bioavailability.Int. J. Pharm. Sci. Res.20201110482210.13040/IJPSR.0975‑8232.11(10).4822‑32
    [Google Scholar]
  60. RahmanM. HussainA. IqbalZ. HarwanshR. SinghL. AhmadS. Nanosuspension: A potential nanoformulation for improved delivery of poorly bioavailable drug.Micro Nanosyst.20135427328710.2174/187640290504131127121625
    [Google Scholar]
  61. AgrawalY.K. PatelV.R. Nanosuspension: An approach to enhance solubility of drugs.J. Adv. Pharm. Technol. Res.201122818710.4103/2231‑4040.8295022171298
    [Google Scholar]
  62. KumarC. S. SekarP. C. SharavananS. P. Development of rutin suspension and evaluation of corneal permeation across the goat cornea.J Chem Pharmaceut Sci201710210821085
    [Google Scholar]
  63. MoravkarK.K. LaddhaU.D. PatilM.D. KaleS.S. GiraseN. BhairavB.A. BhaumikJ. ChalikwarS.S. Extraction of rutin from tagetes erecta (Marigold) and preparation of peroral nano-suspension for effective antitussive/expectorant therapy.Carbohydr. Polym. Technol. Appl.2023510032010.1016/j.carpta.2023.100320
    [Google Scholar]
  64. StahrP.L. KeckC.M. Preservation of rutin nanosuspensions without the use of preservatives.Beilstein J. Nanotechnol.2019101902191310.3762/bjnano.10.18531598456
    [Google Scholar]
  65. HarwanshR.K. DeshmukhR. RahmanM.A. Nanoemulsion: Promising nanocarrier system for delivery of herbal bioactives.J. Drug Deliv. Sci. Technol.20195122423310.1016/j.jddst.2019.03.006
    [Google Scholar]
  66. JaiswalM. DudheR. SharmaP. K. Nanoemulsion: An advanced mode of drug delivery system.3 Biotech20155212312710.1007/s13205‑014‑0214‑0
    [Google Scholar]
  67. GuptaA. EralH.B. HattonT.A. DoyleP.S. Nanoemulsions: Formation, properties and applications.Soft Matter201612112826284110.1039/C5SM02958A26924445
    [Google Scholar]
  68. SharmaS. RabbaniS.A. NarangJ.K. Hyder PottooF. AliJ. KumarS. BabootaS. Role of rutin nanoemulsion in ameliorating oxidative stress: Pharmacokinetic and pharmacodynamics studies.Chem. Phys. Lipids202022810489010.1016/j.chemphyslip.2020.10489032032570
    [Google Scholar]
  69. AhmadM. Sahabjada AkhtarJ. HussainA. Badaruddeen ArshadM. MishraA. Development of a new rutin nanoemulsion and its application on prostate carcinoma PC3 cell line.EXCLI J.20171681082310.17179/excli2016‑66828694767
    [Google Scholar]
  70. AlshahraniS.M. Development and optimization of oral nanoemulsion of rutin for enhancing its dissolution rate, permeability, and oral bioavailability.Pharm. Dev. Technol.202227558859710.1080/10837450.2022.209095735703396
    [Google Scholar]
  71. MacedoA.S. QuelhasS. SilvaA.M. SoutoE.B. Nanoemulsions for delivery of flavonoids: Formulation and in vitro release of rutin as model drug.Pharm. Dev. Technol.201419667768010.3109/10837450.2013.82398923930932
    [Google Scholar]
  72. AlmeidaJ.S. LimaF. RosS.D. BulhõesL.O.S. CarvalhoL.M. BeckR.C.R. Nanostructured systems containing rutin: In vitro antioxidant activity and photostability studies.Nanoscale Res. Lett.20105101603161010.1007/s11671‑010‑9683‑121076700
    [Google Scholar]
  73. SharmaS. SahniJ.K. AliJ. BabootaS. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin – pharmacodynamic and antioxidant studies.Drug Deliv.201522454155110.3109/10717544.2014.89338224625264
    [Google Scholar]
  74. DammakI. de CarvalhoR.A. TrindadeC.S.F. LourençoR.V. do Amaral SobralP.J. Properties of active gelatin films incorporated with rutin-loaded nanoemulsions.Int. J. Biol. Macromol.201798394910.1016/j.ijbiomac.2017.01.09428126457
    [Google Scholar]
  75. BabazadehA. TabibiazarM. HamishehkarH. ShiB. Zein-CMC-PEG Multiple nanocolloidal systems as a novel approach for nutra-pharmaceutical applications.Adv. Pharm. Bull.20199226227010.15171/apb.2019.03031380252
    [Google Scholar]
  76. TuzarZ. KratochvílP. Block and graft copolymer micelles in solution.Adv. Colloid Interface Sci.19766320123210.1016/0001‑8686(76)80009‑7
    [Google Scholar]
  77. WebberS.E. Polymer Micelles: An example of self-assembling polymers.J. Phys. Chem. B1998102152618262610.1021/jp980386o
    [Google Scholar]
  78. PrattenM.K. LloydJ.B. HörpelG. RingsdorfH. Micelle‐forming block copolymers: Pinocytosis by macrophages and interaction with model membranes.Makromol. Chem.1985186472573310.1002/macp.1985.021860406
    [Google Scholar]
  79. GaoY. WangR. HuangT. TianQ. YangC. PilehvarY. WangJ. Synthesis and characterization of rutin-loaded micelles for glioblastoma multiforme treatment: A computational and experimental study.J. Drug Deliv. Sci. Technol.20238610467510.1016/j.jddst.2023.104675
    [Google Scholar]
  80. IbrahimR. KasabriV. SunoqrotS. ShalabiD. AlkhateebR. AlhiariY. Preparation and characterization of rutin-encapsulated polymeric micelles and studies of synergism with bioactive benzoic acids and triazolofluoroquinolones as anticancer nanomedicines.Asian Pac. J. Cancer Prev.202324397798910.31557/APJCP.2023.24.3.97736974553
    [Google Scholar]
  81. KaurJ. GulatiM. Pal KaurI. PatravaleV. DuaK. Kumar SinghS. Polymeric micelles as potent islet amyloid inhibitors: Current advances and future perspectives.Drug Discov. Today202328510357110.1016/j.drudis.2023.10357136990145
    [Google Scholar]
  82. KalhapureR.S. PalekarS. PatelK. MonparaJ. Nanocrystals for controlled delivery: State of the art and approved drug products.Expert Opin. Drug Deliv.202219101303131610.1080/17425247.2022.211057935930427
    [Google Scholar]
  83. SinghV. BansalK. BhatiH. BajpaiM. New insights into pharmaceutical nanocrystals for the improved topical delivery of therapeutics in various skin disorders.Curr. Pharm. Biotechnol.20232591182119810.2174/011389201027622323102707552737921127
    [Google Scholar]
  84. HassanA.S. SolimanG.M. Rutin nanocrystals with enhanced anti-inflammatory activity: Preparation and ex vivo/in vivo evaluation in an inflammatory rat model.Pharmaceutics20221412272710.3390/pharmaceutics1412272736559220
    [Google Scholar]
  85. BohlouliS. Jafarmadar GharehbaghF. Dalir AbdolahiniaE. KouhsoltaniM. EbrahimiG. RoshangarL. ImaniA. SharifiS. Maleki DizajS. Preparation, characterization, and evaluation of rutin nanocrystals as an anticancer agent against head and neck squamous cell carcinoma cell line.J. Nanomater.202120211810.1155/2021/9980451
    [Google Scholar]
  86. MauludinR. MüllerR.H. KeckC.M. Development of an oral rutin nanocrystal formulation.Int. J. Pharm.20093701-220220910.1016/j.ijpharm.2008.11.02919114097
    [Google Scholar]
  87. LiJ. NiW. AishaM. ZhangJ. SunM. A rutin nanocrystal gel as an effective dermal delivery system for enhanced anti-photoaging application.Drug Dev. Ind. Pharm.202147342943910.1080/03639045.2021.189011333617404
    [Google Scholar]
  88. HuL. TangX. CuiF. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.J. Pharm. Pharmacol.201056121527153510.1211/002235704495915563759
    [Google Scholar]
  89. RajabiM. MousaS.A. Lipid nanoparticles and their application in nanomedicine.Curr. Pharm. Biotechnol.201617866267210.2174/138920101766616041515545727087491
    [Google Scholar]
  90. De GaetanoF. CristianoM.C. VenutiV. CrupiV. MajolinoD. PaladiniG. AcriG. TestagrossaB. IrreraA. PaolinoD. TommasiniS. VenturaC.A. StancanelliR. Rutin-loaded solid lipid nanoparticles: Characterization and in vitro evaluation.Molecules2021264103910.3390/molecules2604103933669321
    [Google Scholar]
  91. PandianS.R.K. PavadaiP. VellaisamyS. RavishankarV. PalanisamyP. SundarL.M. ChandramohanV. SankaranarayananM. PanneerselvamT. KunjiappanS. Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor.Naunyn Schmiedebergs Arch. Pharmacol.2021394473574910.1007/s00210‑020‑02015‑933156389
    [Google Scholar]
  92. NouriZ. SajadimajdS. BahramiG. MoradiS. AbdiF. FarzaeiM.H. ArkanE. Solid lipid nanoparticles enhance protective effect of rutin against stz-induced neurotoxicity in pc12 cells through autophagy suppression.J. Nanomater.2022202211310.1155/2022/7254212
    [Google Scholar]
  93. MartinsR.M. de Siqueira MartinsS. BarbosaG.L.F. FonsecaM.J.V. RochetteP.J. MoulinV.J. de FreitasL.A.P. Photoprotective effect of solid lipid nanoparticles of rutin against UVB radiation damage on skin biopsies and tissue-engineered skin.J. Microencapsul.2022397-866867910.1080/02652048.2022.215663136476253
    [Google Scholar]
  94. JoshiM. D. MüllerR. H. Lipid nanoparticles for parenteral delivery of actives.Eur J Pharm Biopharm20097121617210.1016/j.ejpb.2008.09.003
    [Google Scholar]
  95. PardeikeJ. HommossA. MüllerR.H. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products.Int. J. Pharm.20093661-217018410.1016/j.ijpharm.2008.10.00318992314
    [Google Scholar]
  96. KamelR. MostafaD.M. Rutin nanostructured lipid cosmeceutical preparation with sun protective potential.J. Photochem. Photobiol. B2015153596610.1016/j.jphotobiol.2015.09.00226398812
    [Google Scholar]
  97. BabazadehA. GhanbarzadehB. HamishehkarH. Novel nanostructured lipid carriers as a promising food grade delivery system for rutin.J. Funct. Foods20162616717510.1016/j.jff.2016.07.017
    [Google Scholar]
  98. GanL. ZhangC. WuF. LiH. ZhangW. ZhangQ. Microencapsulated nanostructured lipid carriers as delivery system for rutin.Mater. Technol.201833535736310.1080/10667857.2018.1446406
    [Google Scholar]
  99. KumarV. ChaudharyH. KambojA. Development and evaluation of isradipine via rutin-loaded coated solid–lipid nanoparticles.Interv. Med. Appl. Sci.201810423624610.1556/1646.10.2018.4530792921
    [Google Scholar]
  100. KumarV. KharbR. ChaudharyH. Optimization & design of isradipine loaded solid lipid nanobioparticles using rutin by Taguchi methodology.Int. J. Biol. Macromol.20169233834610.1016/j.ijbiomac.2016.07.02027392772
    [Google Scholar]
  101. ZhangT. JiQ. SongJ. LiH. WangX. ShiH. NiuM. ChuT. ZhangF. GuoY. Preparation of nitrogen and sulfur co-doped fluorescent carbon dots from cellulose nanocrystals as a sensor for the detection of rutin.Molecules20222722802110.3390/molecules2722802136432118
    [Google Scholar]
  102. EkaetteI. SaldañaM.D.A. Ultrasound-assisted modification of rutin to nanocrystals and its application in barley starch pyrodextrinization.Food Chem.202134412862610.1016/j.foodchem.2020.12862633243560
    [Google Scholar]
  103. LiB. YangX. Rutin-loaded cellulose acetate/poly(ethylene oxide) fiber membrane fabricated by electrospinning: A bioactive material.Mater. Sci. Eng. C202010911060110.1016/j.msec.2019.11060132228961
    [Google Scholar]
  104. DasM.K. KalitaB. Design and evaluation of phyto-phospholipid complexes (phytosomes) of rutin for transdermal application.J. Appl. Pharm. Sci.2014410515710.7324/JAPS.2014.401010
    [Google Scholar]
  105. GaneshpurkarA. SalujaA.K. The pharmacological potential of rutin.Saudi Pharm. J.201725214916410.1016/j.jsps.2016.04.02528344465
    [Google Scholar]
  106. BazyarH. Zare JavidA. AhangarpourA. ZamanF. HosseiniS.A. ZohooriV. AghamohammadiV. YazdanfarS. Ghasemi Deh CheshmehM. The effects of rutin supplement on blood pressure markers, some serum antioxidant enzymes, and quality of life in patients with type 2 diabetes mellitus compared with placebo.Front. Nutr.202310121442010.3389/fnut.2023.121442037599700
    [Google Scholar]
  107. ClinicalTrials.govInvestigating the potential role of a novel quadrate combination therapy mifepristone(antiprogestrone), tamoxifen, retinoic acid and cannabidiol ( selective cyp 26 inhibitor) for treating early breast cancer.2021Available From: https://classic.clinicaltrials.gov/ct2/show/NCT05016349
    [Google Scholar]
  108. OmarS. Evaluation of the combination effect of rutin and vitamin C supplementation on the oxidative stress and inflammation in hemodialysis patients.Front Pharmacol202213961590
    [Google Scholar]
  109. RaghebS.R. Impact of rutin and vitamin C combination on oxidative stress and glycemic control in patients with type 2 diabetes.Clin Nutr ESPEN2020135128135
    [Google Scholar]
  110. ctvGlucoside- and rutinoside-rich crude material for relieving side effects of COVID-19 vaccines.2022Available From: https://ctv.veeva.com/study/glucoside-and-rutinoside-rich-crude-material-for-relieving-side-effects-of-covid-19-vaccines
  111. ClinicalTrials.gov.Nutraceutical on hyperuricemia.2019Available From: https://classic.clinicaltrials.gov/ct2/show/NCT04161872
  112. ClinicalTrials.gov.Effects of a glucoside- and rutinoside-rich material in chemotherapy-induced peripheral neuropathy and related symptoms.2020Available From: https://classic.clinicaltrials.gov/ct2/show/NCT04669977
  113. ClinicalTrials.gov.Study to investigate the mechanism of action of an oral enzyme treatment with bromelain, trypsin and rutoside versus placebo in subjects with osteoarthritis (WobeSmart).2022Available From: https://classic.clinicaltrials.gov/ct2/show/NCT05038410
  114. ClinicalTrials.gov.A clinical study evaluating the efficacy and safety of retinoic acid in patients with 15q11-q13 duplication syndrome.2022Available From: https://classic.clinicaltrials.gov/ct2/show/NCT05281965
  115. ClinicalTrials.gov.A Trial of All-trans Retinoic Acid (ATRA) in advanced adenoid cystic carcinoma.2020Available From: https://classic.clinicaltrials.gov/ct2/show/NCT03999684
  116. ClinicalTrials.gov.All-trans Retinoic Acid, and Arsenic +/- Idarubicin.2016Available From: https://classic.clinicaltrials.gov/ct2/show/NCT00413166
  117. ctvNivolumab and all-trans retinoic acid for pancreatic cancer.2021Available From: https://ctv.veeva.com/study/nivolumab-and-all-trans-retinoic-acid-for-pancreatic-cancer
  118. ClinicalTrials.gov.Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma.2015Available From: https://classic.clinicaltrials.gov/ct2/show/NCT01985477
  119. ClinicalTrials.gov.Retinoic Acid Homeostasis in Neuropsychiatric Diseases (RAHND).2022Available From: https://classic.clinicaltrials.gov/ct2/show/NCT02439099
  120. ClinicalTrials.gov.RA-2 13-cis Retinoic Acid (Isotretinoin) (RA-2).2018Available From: https://classic.clinicaltrials.gov/ct2/show/NCT02061384
  121. ClinicalTrials.gov.Feasibility of Retinoic Acid Treatment in Emphysema (FORTE).2004Available From: https://classic.clinicaltrials.gov/ct2/show/NCT00000621
  122. ClinicalTrials.gov.Retinoic acid supplementation and subjects with hypercholesterolemia.2015Available From: https://classic.clinicaltrials.gov/ct2/show/NCT02497833
  123. ClinicalTrials.gov.Single dose of 9-cis-retinoic acid in hepatic patients.2013
  124. LARVOLOral Liquid 13-cis-retinoic Acid (13-CRA).2015Available From: https://clin.larvol.com/trial-detail/NCT03291080
  125. ctvCombined Retinoic Acid, Arsenic Trioxide and Chemo for Newly-diagnosed APL.2012Available From: https://ctv.veeva.com/study/combined-retinoic-acidarsenic-trioxide-and-chemo-for-newly-diagnosed-apl
  126. ClinicalTrials.gov.ZD6474 alone and in combination with retinoic acid in pediatric neuroblastoma.2011Available From: https://classic.clinicaltrials.gov/ct2/show/NCT00533169
  127. ClinicalTrials.gov.Intranasal retinoic acid treatment for patients with OlfactoryLOSS: A randomized controlled trial.2019Available From: https://classic.clinicaltrials.gov/ct2/show/NCT03574701
  128. ClinicalTrials.gov.13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung Cancer (13-Cis).2003Available From: https://classic.clinicaltrials.gov/ct2/show/NCT00002586
  129. ClinicalTrials.gov.A study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in primary refractory neuroblastoma patients.2010Available From: https://classic.clinicaltrials.gov/ct2/show/NCT00969722
  130. SharmaS. SahniJ. AliJ. BabootaS. Patent perspective for potential antioxidant compounds-rutin and quercetin.Recent Pat. Nanomed.201331626810.2174/18779123112029990002
    [Google Scholar]
  131. QianM SunJ Metal frame compound nanocarrier delivery system for targeting active cd44 molecule, preparation method therefor, and uses thereof.WO Patent 2019141274A12019
  132. WangZ YuG JianfeiG Manufacturing method based on simultaneous encapsulation of target substance and synthesis of mofs having redox activity.WO Patent 2018045824A12018
  133. SureshC PrasadcuttyB Coated particles and compositions comprising same.KR Patent 101814895B12018
  134. MorariuM Topical macqui berry formulation.US Patent 20070065396A12007
  135. MohammadA. Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance.US Patent 8017147B22011
  136. ShiladityaS SureshR ChawraiS GhoshS GhoshN JainS SadhasivamR BuchtaA Treatments for resistant acne.US Patent 11045479B22021
  137. ColinJ BarrowA Oil producing microbes and methods of modification thereof.AU Patent 2007351658B22013
  138. CurtR Flavonoid composition and usage.JP Patent 6936932B22021
  139. LidiaA.L. LawR.O. Compositions and methods for managing or improving bone disorders, cartilage disorders, or both.AU Patent 2020201457B22022
  140. PhilipJ Methods of making and using compositions comprising flavonoids.EP Patent 2490679B82022
  141. PhilipJ Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds.US Patent 8637569B22014
  142. IndraP AvetikM VenkataS PrakashC MaryC Beverage comprising steviol glycosides.EP Patent 2793618B12017
  143. IndraP AvetikM VenkataS PrakashC MaryC Methods for purifying steviol glycosides and uses of the same.US Patent 20190322691A12019
  144. PaulE Antiviral activity from medicinal mushrooms containing phenyl carboxylate/acrylate compounds.CA Patent 2980173C2021
  145. VaruzhanA AbeticM LydiaA High-purity rebaudioside d and applications.KR Patent 101733515B12017
  146. IndraP GilM YoulungC AvetikM Compositions and methods for improving rebaudioside m solubility.EP Patent 3019198B12021
  147. VargheseJ App specific BACE inhibitors (ASBIs) and uses thereof.US Patent 10835546B22020
  148. MaQ SunJ Micelle nanocarrier delivery system for targeting active cd44 molecule, preparation method therefor, and uses thereof.WO Patent 2019141265A12019
  149. SeungP HongJ WooB Amphiphilic dendron-coils, micelles thereof and uses.US Patent 9770413B22017
  150. YuichiI YutaM Nonionic surfactant composition and cosmetics and topical agents using the same.JP Patent 6105870B22017
  151. KarlR GerhardD Use of catabolic enzymes for the manufacture of a medicament in the treatment of aids and its early stages (las, arc).EP Patent 0309602B11993
  152. AlexanderB Multi-supplement compositions.US Patent 11207388B22021
  153. NúriaA DomènechA SoleyA NuriaG SanzG MolaL JoséD MercedesC Ferment extract of Eupenicillium crustaceum and cosmetic use thereof.US Patent 10512603B22019
  154. MichaelJ ZaworotkoH ClarkeA KapildevP KavuruR DouglasS TwaritaP LissetteM TienT Nutraceutical co-crystal compositions.US Patent 10376521B22019
  155. TakashiS AkikoM TatsuyaI MasakiM WakiJ External dermal composition for anti-ageing and method for producing the same.TW Patent I607764B2017
  156. RolfP Nanocrystals for use in topical cosmetic formulations and method of production thereof.EP Patent 2099420B82017
  157. RobertJ. Drug eluting balloon.CN Patent 108601930B2021
  158. LuisA Formulation containing flavonoid solid lipid nanoparticles and use thereof.BR Patent 102015009018B12021
  159. KevinF DavidE GregoryH Glucokinase (GCK) iRNA compositions and methods of use thereof.US Patent 10844384B22020
  160. JonathanE TimothyK Peptide nanoparticles and uses therefor.US Patent 10905637B22021
  161. MariusM Topical macqui berry formula.US Patent 10993897B22021
  162. NianW Polymer-cyclodextrin-lipid conjugates.US Patent 10064954B22018
  163. LeodevicoL IlagJ SmytheT PeterE RichardS Sugar extract.US Patent 9717771B22017
  164. ShinotoR All-natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and bioavailability.JP Patent 5643166B22014
  165. DarrellJ Lipid vesicle compositions and methods of use.US Patent 9907753B22018
/content/journals/pnt/10.2174/0122117385308249240723111115
Loading
/content/journals/pnt/10.2174/0122117385308249240723111115
Loading

Data & Media loading...


  • Article Type:
    Review Article
Keyword(s): bioavailability; clinical trials; drug delivery; nano-formulations; patents; Rutin
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test